Share Success: Letters From Readers
I: From Lydia
at Testimonial Submit Form Wednesday, July 20, 2016 at 16:27:30
Hi, my name is Lydia.
I had a bone density test July 2013 and the findings were not what I was expecting. I had Osteopenia.
I was taking calcium pills that was recommended by the doctor and they did not help.
I did some research and came across Ezorb.
I started taking them about 2 years ago and was dreading another bone density test. On June 3, 2016 I went for another bone density test and the results was much better.
There has been an increase in bone mineral density when compared to the previous study of 07/01/2013. I no longer have osteopenia.
II: From Graciela G.
Received at Testimonial Submit Form Thursday, April 28, 2016 at 10:58:47
Hi, my name is Graciela Grammer. I have reported on my case but it got better again!
I was diagnosed with osteoporosis on March 2014. My Dr put me on Fosamax. Read the side effects no way! I looked online found EZorb and started taking it.
I had a bone scan my osteoporosis showed moderate continue to take it all 2015. In February 2016 I had another bone scan the osteoporosis was gone!
I am a firm believer of the EZorb calcium and will take it for the rest of my life.
III: From Janel
Received at Testimonial
Submit Form Tuesday, March 15, 2016 at 17:01:21
Hi, I just wanted to let you know how much better I am feeling. Since I have been taking the EZorb cap, the aches and pain in my knees and hands are almost gone!
I still feel them, somewhat, but they are not hurting me like they were. When I stopped taking it is all came back. So I wanted to thank-u so very much for this product. Feeling much better yaaaay!
the Desk of EZorb Newsletter Editor:
newsletter is now read by over 95,000 subscribers
worldwide. Success stories you have contributed over
the years have had a great impact on many people's
quality of life. Your continuous support will be
greatly appreciated by tens of thousands who have been
suffering and would continuously suffer, without your
help! Please email your
story to sharesuccess @ ezorbonline.com
or simply post it at Testimonial
Submit Form. Your personal information will never be
revealed to the public. If your testimonial is selected for publication, you will receive a generous gift to show our appreciation of your effort.
Research News: Coronary Heart Disease Risk Higher for Early Menopause
Women who experience premature or early-onset menopause before the age of 45 years are at increased risk of coronary heart disease (CHD) and cardiovascular and overall mortality, a review of the research indicates.
Given that as many as 10% of women experience natural menopause before 45 years of age, this finding "may have important clinical and public health implications", says the team in JAMA Cardiology.
Agreeing with this, JoAnn Manson (Harvard Medical School, Boston, Massachusetts, USA) and Teresa Woodruff (Northwestern University, Chicago, Illinois, USA) say in a related commentary: "The recognition that women with early reproductive decline constitute a population at increased vascular risk provides important opportunities for early intervention in terms of both risk factor modification and, when appropriate, hormonal treatment."
The researchers, led by Taulant Muka (Erasmus University Medical Center, Rotterdam, the Netherlands), identified 32 studies including 310,329 women.
Women with menopause onset before 45 years of age were a significant 1.50 times more likely to develop CHD than their peers aged 45 years and older. They were also 1.11 times more likely to develop fatal CHD, 1.19 times more likely to die from cardiovascular disease and 1.12 more likely to die from any cause.
Early-onset menopause was not associated with an increased risk of stroke or death from stroke, however.
For women experiencing menopause between the ages of 50 and 54 years, there was a 13% decreased risk of fatal CHD, compared with their peers younger than 50 years, and again there was no effect on stroke.
The researchers were keen to determine the effects of time since menopause on the risk of developing intermediate cardiovascular factors but, being reported on in just four observational studies and with inconsistent results, they only identified a need for further research on this and the mechanisms linking early menopause to adverse cardiovascular outcomes.
Early loss of ovarian function leading to endothelial dysfunction, inflammation, immune dysfunction and in turn vascular damage is thought to be one of the primary underlying mechanisms, notes editorialist Elizabeth McNally (Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA).
But she points out that age at onset of menopause is under genetic influence and suggests that "more direct molecular mechanisms may be responsible for the tie to cardiovascular disease, as defective DNA repair can alter immune and vascular health."
Indeed, McNally and Muka et al both cite genome-wide association studies that have identified, and validated in additional cohorts, genetic polymorphisms linked to early menopause and cardiovascular disease that are involved in inflammatory response, oxidative stress and genome stability.
Original research was published in reported in 9-15-2016 issue of Coronary Heart Disease.
Asked Questions & Answers
Calcium has set a new world record of absorption rate.
You can compare EZorb with other calcium supplements
by using the simple step-by-step instructions we
provide. E-mail your request to test @ elixirindustry.com
for a copy of the instructions.
What Are Others Saying About EZorb and Marvlix?
EZorb and Marvlix have restored confidence in thousands of men
and women. It has brought happiness and healthy life
to families around the world. Click here
to read what people say about EZorb and Marvlix.